Previous metabolomic and transcriptomic study of Cotadutide (GLP-1R/GCGR dual agonist) in hepatic fibrosis identified its effects on pathways related to lipogenesis, fibrosis, and inflammation (20). This evidence concerns the gene GLP1R and Hepatic fibrosis.